Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata. - King B; McMichael A; Sinclair R; Vañó-Galvan S; Wolk R; Woodworth D; Soma K; Robbana F; Lejeune A; Napatalung L; Law E; Wajsbrot D; et al. (Dermatology and therapy, 2025)